Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew B Reeves

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Cell Reports|July 19, 2018
A Virally Encoded DeSUMOylase Activity Is Required for Cytomegalovirus Reactivation from LatencyEmma L Poole, Verity G Kew, Jonathan C H Lau, et al.
Frontiers in Immunology|October 11, 2017
Human Cytomegalovirus Delays Neutrophil Apoptosis and Stimulates the Release of a Prosurvival SecretomeJoanna M Pocock, Daniel M L Storisteanu, Matthew B Reeves, et al.
Ebiomedicine|November 19, 2019
Seronegative patients vaccinated with cytomegalovirus gB-MF59 vaccine have evidence of neutralising antibody responses against gB early post-transplantationIlona Baraniak, Ariane C Gomes, Isabella Sodi, et al.
Frontiers in Immunology|January 2, 2023
HCMV carriage in the elderly diminishes anti-viral functionality of the adaptive immune response resulting in virus replication at peripheral sitesEmma L Davies, Mahlaqua Noor, Eleanor Y Lim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2005
Human cytomegalovirus encodes an MHC class I-like molecule (UL142) that functions to inhibit NK cell lysisMark R Wills, Omodele Ashiru, Matthew B Reeves, et al.
The Journal of Infectious Diseases|March 13, 2018
Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine With MF59: Anti-AD2 Levels Correlate With Protection From ViremiaIlona Baraniak, Barbara Kropff, Gary R McLean, et al.
The Journal of General Virology|June 13, 2023
A temperature-dependent virus-binding assay reveals the presence of neutralizing antibodies in human cytomegalovirus gB vaccine recipients' seraAriane C Gomes, Ilona A Baraniak, Megan R McIntosh, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2018
Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodiesIlona Baraniak, Barbara Kropff, Lyn Ambrose, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2021
Characterisation of B.1.1.7 and Pangolin coronavirus spike provides insights on the evolutionary trajectory of SARS-CoV-2Samuel J Dicken, Matthew J Murray, Lucy G Thorne, et al.
Frontiers in Immunology|April 29, 2021
Latent Cytomegalovirus-Driven Recruitment of Activated CD4+ T Cells Promotes Virus ReactivationSarah E Jackson, Kevin C Chen, Ian J Groves, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Cell Reports|July 19, 2018
A Virally Encoded DeSUMOylase Activity Is Required for Cytomegalovirus Reactivation from LatencyEmma L Poole, Verity G Kew, Jonathan C H Lau, et al.
Frontiers in Immunology|October 11, 2017
Human Cytomegalovirus Delays Neutrophil Apoptosis and Stimulates the Release of a Prosurvival SecretomeJoanna M Pocock, Daniel M L Storisteanu, Matthew B Reeves, et al.
Ebiomedicine|November 19, 2019
Seronegative patients vaccinated with cytomegalovirus gB-MF59 vaccine have evidence of neutralising antibody responses against gB early post-transplantationIlona Baraniak, Ariane C Gomes, Isabella Sodi, et al.
Frontiers in Immunology|January 2, 2023
HCMV carriage in the elderly diminishes anti-viral functionality of the adaptive immune response resulting in virus replication at peripheral sitesEmma L Davies, Mahlaqua Noor, Eleanor Y Lim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 23, 2005
Human cytomegalovirus encodes an MHC class I-like molecule (UL142) that functions to inhibit NK cell lysisMark R Wills, Omodele Ashiru, Matthew B Reeves, et al.
The Journal of Infectious Diseases|March 13, 2018
Epitope-Specific Humoral Responses to Human Cytomegalovirus Glycoprotein-B Vaccine With MF59: Anti-AD2 Levels Correlate With Protection From ViremiaIlona Baraniak, Barbara Kropff, Gary R McLean, et al.
The Journal of General Virology|June 13, 2023
A temperature-dependent virus-binding assay reveals the presence of neutralizing antibodies in human cytomegalovirus gB vaccine recipients' seraAriane C Gomes, Ilona A Baraniak, Megan R McIntosh, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2018
Protection from cytomegalovirus viremia following glycoprotein B vaccination is not dependent on neutralizing antibodiesIlona Baraniak, Barbara Kropff, Lyn Ambrose, et al.
Biorxiv : the Preprint Server for Biology|April 1, 2021
Characterisation of B.1.1.7 and Pangolin coronavirus spike provides insights on the evolutionary trajectory of SARS-CoV-2Samuel J Dicken, Matthew J Murray, Lucy G Thorne, et al.
Frontiers in Immunology|April 29, 2021
Latent Cytomegalovirus-Driven Recruitment of Activated CD4+ T Cells Promotes Virus ReactivationSarah E Jackson, Kevin C Chen, Ian J Groves, et al.
Pageof 5